Kensaku Nishimura

Perioperative safety and oncological outcomes of robot-assisted radical cystectomy in patients aged ≥80 years: A propensity score-matched multi-institutional study.

Journal: Surgical oncology

Published: January 29, 2026

Real-world efficacy and safety of pembrolizumab plus lenvatinib in patients with metastatic renal cell carcinoma: a multi-institutional retrospective study.

Journal: Scientific reports

Published: July 06, 2025

Preoperative CRP is a predictive factor for prolonged hospital stay after radical cystectomy for bladder cancer.

Journal: BMC urology

Published: May 08, 2025

Efficacy of Second-line Nivolumab Versus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma With Bone Metastases.

Journal: Anticancer research

Published: December 20, 2024

A Case of Secondary Extramammary Paget's Disease Developed at 11 Years after Cystectomy

Journal: Hinyokika kiyo. Acta urologica Japonica

Published: December 05, 2024

Clinical outcomes of first-line combination therapy with immune checkpoint inhibitor for metastatic non-clear cell renal cell carcinoma: a multi-institutional retrospective study in Japan.

Journal: International journal of clinical oncology

Published: June 23, 2024

Determination of enzalutamide long-term safety and efficacy for castration-resistant prostate cancer patients after combined anti-androgen blockade followed by alternative anti-androgen therapy: a multicenter prospective DELC study.

Journal: Japanese journal of clinical oncology

Published: October 09, 2023

A Long-Term Survival Case of Paraganglioma Treated with Repeated Surgical Resection

Journal: Hinyokika kiyo. Acta urologica Japonica

Published: January 11, 2023

Real-world efficacy and safety of nivolumab plus ipilimumab in untreated metastatic renal cell carcinoma, and the impact of previous nephrectomy on clinical outcome: Japanese multi-institutional retrospective study.

Journal: International journal of clinical oncology

Published: April 17, 2022

A comparative study on nivolumab and axitinib as secondary treatment in patients with metastatic renal cell carcinoma: A multi-institutional retrospective study in Japan.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: March 02, 2022

Osteosarcoma of the bladder: a case report.

Journal: Journal of medical case reports

Published: February 16, 2022

Real-world Outcomes of Tyrosine Kinase Inhibitors Immediately After Immune Checkpoint Inhibitors in Renal Cell Carcinoma.

Journal: Anticancer research

Published: August 29, 2021

Perioperative safety and oncological outcomes of robot-assisted radical cystectomy in patients aged ≥80 years: A propensity score-matched multi-institutional study.

Perioperative safety and oncological outcomes of robot-assisted radical cystectomy in patients aged ≥80 years: A propensity score-matched multi-institutional study.

Real-world efficacy and safety of pembrolizumab plus lenvatinib in patients with metastatic renal cell carcinoma: a multi-institutional retrospective study.

Real-world efficacy and safety of pembrolizumab plus lenvatinib in patients with metastatic renal cell carcinoma: a multi-institutional retrospective study.

Preoperative CRP is a predictive factor for prolonged hospital stay after radical cystectomy for bladder cancer.

Preoperative CRP is a predictive factor for prolonged hospital stay after radical cystectomy for bladder cancer.

Efficacy of Second-line Nivolumab Versus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma With Bone Metastases.

Efficacy of Second-line Nivolumab Versus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma With Bone Metastases.

A Case of Secondary Extramammary Paget's Disease Developed at 11 Years after Cystectomy

A Case of Secondary Extramammary Paget's Disease Developed at 11 Years after Cystectomy

Clinical outcomes of first-line combination therapy with immune checkpoint inhibitor for metastatic non-clear cell renal cell carcinoma: a multi-institutional retrospective study in Japan.

Clinical outcomes of first-line combination therapy with immune checkpoint inhibitor for metastatic non-clear cell renal cell carcinoma: a multi-institutional retrospective study in Japan.

Determination of enzalutamide long-term safety and efficacy for castration-resistant prostate cancer patients after combined anti-androgen blockade followed by alternative anti-androgen therapy: a multicenter prospective DELC study.

Determination of enzalutamide long-term safety and efficacy for castration-resistant prostate cancer patients after combined anti-androgen blockade followed by alternative anti-androgen therapy: a multicenter prospective DELC study.

A Long-Term Survival Case of Paraganglioma Treated with Repeated Surgical Resection

A Long-Term Survival Case of Paraganglioma Treated with Repeated Surgical Resection

Real-world efficacy and safety of nivolumab plus ipilimumab in untreated metastatic renal cell carcinoma, and the impact of previous nephrectomy on clinical outcome: Japanese multi-institutional retrospective study.

Real-world efficacy and safety of nivolumab plus ipilimumab in untreated metastatic renal cell carcinoma, and the impact of previous nephrectomy on clinical outcome: Japanese multi-institutional retrospective study.

A comparative study on nivolumab and axitinib as secondary treatment in patients with metastatic renal cell carcinoma: A multi-institutional retrospective study in Japan.

A comparative study on nivolumab and axitinib as secondary treatment in patients with metastatic renal cell carcinoma: A multi-institutional retrospective study in Japan.

Osteosarcoma of the bladder: a case report.

Osteosarcoma of the bladder: a case report.

Real-world Outcomes of Tyrosine Kinase Inhibitors Immediately After Immune Checkpoint Inhibitors in Renal Cell Carcinoma.

Real-world Outcomes of Tyrosine Kinase Inhibitors Immediately After Immune Checkpoint Inhibitors in Renal Cell Carcinoma.

Perioperative safety and oncological outcomes of robot-assisted radical cystectomy in patients aged ≥80 years: A propensity score-matched multi-institutional study.

Perioperative safety and oncological outcomes of robot-assisted radical cystectomy in patients aged ≥80 years: A propensity score-matched multi-institutional study.